Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Maytansinoid-conjugated humanised monoclonal antibody against CD56

EU orphan designation number: EU/3/10/835
Active ingredient: Maytansinoid-conjugated humanised monoclonal antibody against CD56
Indication: Treatment of multiple myeloma
Sponsor: ImmunoGen Europe Limited
c/o Reeves LLC, 24 Chiswell Street, Third Floor, London EC1Y 4YX, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2011 Centralised Orphan - Designation EMA/OD/115/10 (2011)1301 of 23/02/2011
25/07/2012 Other procedure EMA/OD/115/10
30/07/2014 Centralised Orphan - Removal of orphan designation from Community Register